Illegal immigration continues to be a flashpoint in national politics, and the trial of George Alan Kelly has gained national attention.

Federal officials are joining forces to go after a Sinaloa cartel boss they believe responsible for sending thousands of ...

An Akebia Therapeutics drug for a type of anemia has won FDA approval, a regulatory decision that comes nearly two years after the agency rejected the drug due to safety concerns. Safety remains a ...

There was chaos on the ground and in the air in the New York metro area Friday morning as the Holland Tunnel was temporarily closed for inspection and New York-area flights were grounded after a 4 ...

The goal of Measure 110 was to keep drug users from being criminalized and instead address root causes of their addiction by diverting them to recovery programs and investing in community ...

Federal authorities discovered a massive drug-trafficking tunnel underneath the California-Mexico border, seizing one ton of cocaine and seven tons of marijuana and arresting six people. “We believe ...

The tunnel will consist of two tunnels, each around two miles long. Credit: Amtrak The $6bn Frederick Douglass Tunnel project in Maryland, US will be overseen by a joint venture of AECOM and Jacobs ...

London's newest transport expansion of the Silvertown Tunnel was not something that outsiders of the region might think could be controversial. However, since its approval back in 2018, many Londoners ...

O. D. One gene. The drug will use all to extend the life of patients and the discovery of a protein mutation that causes A. L. S. In europe and the U. S. A. L. S. Affects one in 50,000.

O. D. One gene. The drug will use all to extend the life of patients and the discovery of a protein mutation that causes A. L. S. In europe and the U. S. A. L. S. Affects one in 50,000.

The number of positive drug tests for marijuana and nearly all other substances identified among truck drivers declined in calendar year 2023 compared with 2022, according to year-end numbers ...

WASHINGTON — (AP) — The maker of a drug for Lou Gehrig's disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn't help ...